102 related articles for article (PubMed ID: 1529899)
21. Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction.
Francis CW; Connaghan DG; Marder VJ
Circulation; 1986 Nov; 74(5):1027-36. PubMed ID: 3533310
[TBL] [Abstract][Full Text] [Related]
22. Effect of reperfusion on electrocardiographic and enzymatic infarct size: results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction.
Hackworthy RA; Sorensen SG; Fitzpatrick PG; Barry WH; Menlove RL; Rothbard RL; Anderson JL
Am Heart J; 1988 Oct; 116(4):903-14. PubMed ID: 3051985
[TBL] [Abstract][Full Text] [Related]
23. [The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct].
Malý J; Pecka M; Pidrman V; Hamet A; Gregor J; Vodicka L; Siroký O; Tichý M
Vnitr Lek; 1991 Mar; 37(3):229-37. PubMed ID: 2031311
[TBL] [Abstract][Full Text] [Related]
24. Thrombolytic therapy with streptokinase stimulates collagen breakdown.
Peuhkurinen KJ; Risteli L; Melkko JT; Linnaluoto M; Jounela A; Risteli J
Circulation; 1991 Jun; 83(6):1969-75. PubMed ID: 2040049
[TBL] [Abstract][Full Text] [Related]
25. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD
Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675
[TBL] [Abstract][Full Text] [Related]
26. Contribution of creatine kinase MB mass concentration at admission to early diagnosis of acute myocardial infarction.
Bakker AJ; Gorgels JP; van Vlies B; Koelemay MJ; Smits R; Tijssen JG; Haagen FD
Br Heart J; 1994 Aug; 72(2):112-8. PubMed ID: 7917680
[TBL] [Abstract][Full Text] [Related]
27. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor.
Butler J; Parker D; Pillai R; Westaby S; Shale DJ; Rocker GM
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):25-30. PubMed ID: 8419705
[TBL] [Abstract][Full Text] [Related]
28. Effects of intravenous streptokinase and CLS 2210 (calcium dobesilate) on the biochemical markers of early acute myocardial infarction: a historic comparison with both studies.
Szlavy L; Repa I; Lengye I; Lamboy L
Angiology; 1992 Sep; 43(9):741-7. PubMed ID: 1514710
[TBL] [Abstract][Full Text] [Related]
29. Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator.
Peuhkurinen K; Risteli L; Jounela A; Risteli J
Am Heart J; 1996 Jan; 131(1):7-13. PubMed ID: 8554022
[TBL] [Abstract][Full Text] [Related]
30. Early diagnosis of acute myocardial infarction by CK-MB mass measurements.
Collinson PO; Rosalki SB; Kuwana T; Garratt HM; Ramhamadamy EM; Baird IM; Greenwood TW
Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():43-7. PubMed ID: 1536524
[TBL] [Abstract][Full Text] [Related]
31. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase.
Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
Thromb Haemost; 1996 Sep; 76(3):339-43. PubMed ID: 8883267
[TBL] [Abstract][Full Text] [Related]
32. Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction.
Puleo PR; Meyer D; Wathen C; Tawa CB; Wheeler S; Hamburg RJ; Ali N; Obermueller SD; Triana JF; Zimmerman JL
N Engl J Med; 1994 Sep; 331(9):561-6. PubMed ID: 7702648
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic value of an early peak CK-MB in plasma of patients treated with streptokinase for acute myocardial infarction].
Stanisławska J; Opolski G; Słomka K; Niemczyk M; Górecki A; Tadeusiak W; Kraska T
Pol Arch Med Wewn; 1992 Nov; 88(5):336-40. PubMed ID: 1300554
[TBL] [Abstract][Full Text] [Related]
34. In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis.
Ziakas A; Gavrilidis S; Giannoglou G; Souliou E; Gemitzis K; Kalampalika D; Vayona MA; Pidonia I; Parharidis G; Louridas G
Angiology; 2006; 57(3):283-93. PubMed ID: 16703188
[TBL] [Abstract][Full Text] [Related]
35. [Changes in the plasma levels of fibrinopeptide A in acute myocardial infarction after administration of intravenous streptokinase].
Amoriello A; Piantadosi FR; Piccenna L; Amoriello A; Vacca C; Eliseo V
Cardiologia; 1988 Dec; 33(12):1121-6. PubMed ID: 3255497
[No Abstract] [Full Text] [Related]
36. Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase.
Salvioni A; Marenzi GC; Agostoni P; Grazi S; Guazzi MD
Eur Heart J; 1994 May; 15(5):654-9. PubMed ID: 8056006
[TBL] [Abstract][Full Text] [Related]
37. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
38. Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction.
Thomson SP; Gibbons RJ; Smars PA; Suman VJ; Pierre RV; Santrach PJ; Jiang NS
Ann Intern Med; 1995 Mar; 122(5):335-41. PubMed ID: 7847644
[TBL] [Abstract][Full Text] [Related]
39. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
[TBL] [Abstract][Full Text] [Related]
40. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Hackworthy RA; Sorensen SG; Menlove RL; Anderson JL
Drugs; 1987; 33 Suppl 3():198-208. PubMed ID: 3315592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
